Sign inJoin waitlistJoin the waitlist

Rajasree Chowdry

Associate Professor of Clinical Medicine · Louisiana State University School of Medicine

Credentials: · · · · ·

History

Louisiana State University School of Medicine
Present
Louisiana State University School of Medicine
Present

Hematology and Medical Oncology
Tulane University School of Medicine
2014–2017
Internal Medicine
Emory University School of Medicine
2011–2014
George Washington Univ Sch of Med
2006–2010
George Washington University
2002–2006

Research

Clinical efficacy of targeted biologic agents as second-line therapy of advanced thyroid cancer
The Oncologist · 2013 · 13 citations
Unusual suspects: pulmonary opportunistic infections masquerading as tumor metastasis in a patient with adrenocorticotropic hormone-producing pancreatic neuroendocrine cancer
Therapeutic Advances in Medical Oncology · 2012 · First of 7 authors · 9 citations
A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer
Systematic review or meta-analysis · Kidney Cancer · 2022 · 9 citations

Taofeek Owonikoko
2 papers
AC
Amanda Cooke
1 paper
AL
Arya Loghmani
1 paper · 1 as a resident
Caitlin Sullivan
1 paper · 1 as a resident
CS
Cameron Simmons
1 paper
Chandar Bhimani
1 paper
CP
Channing Paller
1 paper
Dong Shin
1 paper
FK
Fadlo Khuri
1 paper
Gabriel Sica
1 paper
Jason Webb
1 paper
Joshua DeBlieux
1 paper · 1 as a resident

Clinical trials

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2027
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Site PI · Recruiting · Phase 3
Canadian Cancer Trials Group
2025–2031
Vitamin D for Prostate Endocrine Therapy
Site PI · Recruiting · Phase 3
University of Rochester
2023–2029
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Site PI · Recruiting · Phase 2, Phase 3
National Cancer Institute (NCI)
2021–2027